Join to View Full Profile
5777 E. Mayo BoulevardPhoenix, AZ 85050
Dr. Rosenthal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allison Rosenthal is a hematologist in Phoenix, AZ and is affiliated with Mayo Clinic Hospital. She received her medical degree from Arizona College of Osteopathic Medicine of Midwestern University and has been in practice 8 years. She specializes in hematologic oncology and is experienced in cutaneous lymphomas, non-hodgkin lymphoma, thrombocytopenia, hodgkin's lymphoma, and lymphoma. She has more than 80 publications and over 500 citings.
Education & Training
Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology, 2012 - 2015
Creighton University School of Medicine-PhoenixResidency, Internal Medicine, 2009 - 2012
Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2009
Certifications & Licensure
AZ State License 2012 - 2027
MN State License 2015 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2014, 2017
- CMS Meaningful Use Stage 2 Certification Access Profiler Enterprise, EMRConnect, 2014, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2014, 2017
Clinical Trials
- Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL Start of enrollment: 2020 Sep 07
- Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Start of enrollment: 2021 Apr 01
- DALY II USA/ MB-CART2019.1 for DLBCL Start of enrollment: 2021 May 25
Roles: Contact
Publications & Presentations
PubMed
- Neurotoxicity in Older Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Study.Aung M Tun, Romil Patel, Frederique St-Pierre, Jenny Ouchveridze, Alex Niu
Transplantation and Cellular Therapy. 2026-04-02 - Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort study.Yoshito Nishimura, Thomas Habermann, Morie Gertz, Luis Porrata, Patrick Johnston
Blood Advances. 2026-03-10 - Anatomical Localization-Based Analysis of Relapsed Secondary Central Nervous System Aggressive B-Cell Lymphoma (R-SCNSL).Izel Okcu, Yucai Wang, Zhuo Li, Launia J White, Patrick B Johnston
Hematological Oncology. 2026-03-01
Press Mentions
Cancer Before 40: Mayo Clinic Expert Shares 3 Topics That Younger Patients Often Want to DiscussJune 16th, 2025- How Personalized Vaccines Target Cancer TumorsApril 10th, 2025
- Ask Me Anything: LymphomaMarch 25th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
